+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dystonia Drug"

From
Dystonia - Pipeline Insight, 2024 - Product Thumbnail Image

Dystonia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Cervical Dystonia - Epidemiology Forecast - 2034 - Product Thumbnail Image

Cervical Dystonia - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 75 Pages
  • Global
From
Cervical Dystonia - Pipeline Insight, 2024 - Product Thumbnail Image

Cervical Dystonia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cervical Dystonia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cervical Dystonia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
From
Cervical Dystonia Therapeutics Market 2021-2025 - Product Thumbnail Image

Cervical Dystonia Therapeutics Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
From
  • 19 Results (Page 1 of 1)
Loading Indicator

The Dystonia Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat dystonia, a neurological disorder characterized by involuntary muscle contractions and spasms. These drugs are used to reduce the severity of symptoms, such as muscle spasms, cramps, and tremors. Commonly prescribed drugs include botulinum toxin, anticholinergics, and dopamine agonists. Other treatments, such as physical therapy, may also be used to manage dystonia. The Dystonia Drug market is highly competitive, with many companies offering products to treat the disorder. Some of the major players in the market include Allergan, Merz Pharmaceuticals, Teva Pharmaceuticals, AbbVie, and Ipsen. Show Less Read more